EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Cholinesterase Activity and the Metabolic Syndrome—Dissecting Fatty Liver, Insulin Resistance and Dysglycaemia

Martin Heni iD, Julia Hummel, Louise Fritsche iD, Robert Wagner, Lasse Relker, Jürgen Machann, Fritz Schick, Andreas L Birkenfeld, Erwin Schleicher, Alfred Königsrainer, Hans-Ulrich Häring, Norbert Stefan und 2 weitere

Liver International · 2025

DOI: 10.1111/liv.70046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Martin Heni und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetology, Department of Internal Medicine I, University of Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Insulin Resistance, Metabolic Syndrome, Butyrylcholinesterase, Fatty Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims While low plasma butyrylcholinesterase (BChE) is a well‐established marker of reduced liver synthesis capacity, the clinical significance of elevated BChE is unclear. In small studies, high BChE has long been suspected in hepatic steatosis and metabolic syndrome. We aimed to clarify the relation between BChE, liver fat and glucose metabolism in deeply phenotyped cohorts.

Methods

Plasma BChE activity was measured in 844 humans (554 women) of the cross‐sectional Tübingen Diabetes Family Study, with a wide BMI range (17.7–55.1 kg/m 2 ). It was furthermore measured before and after two independent lifestyle intervention studies in 215 and 116 participants. Liver fat was quantified with 1 H‐MR‐spectroscopy, and metabolism was assessed by oral glucose tolerance tests.

Results

BChE was positively associated with liver fat, independent of sex, age and BMI. BChE was higher in participants with metabolic syndrome. BChE was positively associated with fasting and 2‐h glycaemia, independent of sex, age and BMI. BChE was negatively associated with insulin sensitivity, independent of sex, age, BMI and liver fat. The reduction of liver fat and improvement in insulin sensitivity during lifestyle interventions are associated with the reduction in BChE, independent of body weight loss.

Conclusions

Higher plasma BChE activity is linked to liver fat accumulation, as well as impaired glucose tolerance and insulin resistance, independent of liver fat. This suggests that BChE could be a marker for processes in hepatocytes that contribute to impaired glucose metabolism. Further investigations are needed to clarify the mechanistic contribution and potential diagnostic value of elevated BChE in hepatic steatosis and metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceMetabolic SyndromeButyrylcholinesteraseFatty LiverHumansFemaleMaleMiddle AgedCross-Sectional StudiesAdultLiverGlucose Tolerance TestBlood GlucoseAgedBiomarkers

Stichwörter der Autor:innen

cholinesteraseinsulin sensitivityliver fatmetabolic syndrome

Substanzen

ButyrylcholinesteraseBlood GlucoseBiomarkers

Autor:innen und Institutionen

  • Division of Endocrinology and Diabetology, Department of Internal Medicine I, University of Ulm, Ulm, Germany.
  • Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Division of Diabetology, Endocrinology and Nephrology, Department of Internal Medicine IV, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

ORCID-Profile: Martin Heni, Louise Fritsche

Förderung

  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Heni, M., Hummel, J., Fritsche, L., Wagner, R., Relker, L., Machann, J., Schick, F., Birkenfeld, A. L., Schleicher, E., Königsrainer, A., Häring, H. U., Stefan, N., Fritsche, A., & Peter, A. (2025). Elevated Cholinesterase Activity and the Metabolic Syndrome—Dissecting Fatty Liver, Insulin Resistance and Dysglycaemia. Liver International. https://doi.org/10.1111/liv.70046

Vancouver

Heni M, Hummel J, Fritsche L, Wagner R, Relker L, Machann J, et al. Elevated Cholinesterase Activity and the Metabolic Syndrome—Dissecting Fatty Liver, Insulin Resistance and Dysglycaemia. Liver International. 2025. doi:10.1111/liv.70046

BibTeX
@article{Heni2025,
  author = {Heni, Martin and Hummel, Julia and Fritsche, Louise and Wagner, Robert and Relker, Lasse and Machann, Jürgen and Schick, Fritz and Birkenfeld, Andreas L and Schleicher, Erwin and Königsrainer, Alfred and Häring, Hans-Ulrich and Stefan, Norbert and Fritsche, Andreas and Peter, Andreas},
  title = {Elevated Cholinesterase Activity and the Metabolic Syndrome—Dissecting Fatty Liver, Insulin Resistance and Dysglycaemia},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70046}
}
Kostenlos starten →